A systematic review on Drug Re-profiling/Re-Purposing
May 2023
in “IARS international research journal”
TLDR
The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.
The document discusses the potential of drug repurposing, a process that provides patients with access to medications with known safety profiles more quickly and inexpensively than developing new drugs. This process has been used with drugs like Sildenafil, Chloroquine, and Metformin, which are now used in multiple disease models. Despite challenges, drug repurposing is a crucial part of drug rediscovery strategies, benefiting patients with various serious illnesses, including different types of cancer, the novel coronavirus (SARS-CoV-2), and some orphan diseases.
View this study on researth.iars.info →
Cited in this study
research Preparation of topical bimatoprost with enhanced skin infiltration and in vivo hair regrowth efficacy in androgenic alopecia
Bimatoprost cream can help regrow hair in baldness.
research Preparation and Optimization of Garlic Oil/Apple Cider Vinegar Nanoemulsion Loaded with Minoxidil to Treat Alopecia
research Comment on “Low dose oral minoxidil for treating alopecia: A 3-year North American retrospective case series”: Adding further evidence about side effects
Low-dose oral minoxidil for hair loss seems to have rare side effects, but more research is needed to confirm its safety.
research Low‐dose oral minoxidil improves global hair density and length in children with loose anagen hair syndrome
Low-dose oral minoxidil increases hair thickness and length in children with a hair disorder called Loose Anagen Hair Syndrome.